Relevant bibliographies by topics / Alzheimer's disease – Diagnosis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Alzheimer's disease – Diagnosis'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Alzheimer's disease – Diagnosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Alzheimer's disease – Diagnosis"

1

Sianturi, Aditya Gloria Monalisa. "Stadium, Diagnosis, dan Tatalaksana Penyakit Alzheimer." Majalah Kesehatan Indonesia 2, no. 2 (October 25, 2021): 39–44. http://dx.doi.org/10.47679/makein.202132.

Full text
Abstract:
Dementia is a general term for loss of memory that can occur along with behavioral or psychological symptoms in patients. The first cause of dementia patients is Alzheimer's disease. Alzheimer’s disease is a brain degenerative disease and the most common cause of dementia. In Alzheimer’s disease, there are three development stages, which is stage 1, stage 2, and stage 3 with different clinical symptoms at each stage. There are several clinical criteria for establishing a definitive diagnosis of Alzheimer’s disease and also support examinations have to be carried out. Until now, Alzheimer’s tre
APA, Harvard, Vancouver, ISO, and other styles
2

Dinsmore, Steven T. "Alzheimer's disease diagnosis." Journal of the American Osteopathic Association 99, no. 9_suppl (September 1, 1999): S1. http://dx.doi.org/10.7556/jaoa.1999.99.9.s1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zarrouk, Amira, Meryam Debbabi, Maryem Bezine, El Mostafa Karym, Asmaa Badreddine, Olivier Rouaud, Thibault Moreau, et al. "Lipid Biomarkers in Alzheimer's Disease." Current Alzheimer Research 15, no. 4 (February 22, 2018): 303–12. http://dx.doi.org/10.2174/1567205014666170505101426.

Full text
Abstract:
Background: There are now significant evidences that lipid metabolism is affected in numerous neurodegenerative diseases including Alzheimer’s disease. These dysfunctions lead to abnormal levels of certain lipids in the brain, cerebrospinal fluid and plasma. It is consequently of interest to establish lipid profiles in neurodegenerative diseases. This approach, which can contribute to identify lipid biomarkers of Alzheimers' disease, can also permit to identify new therapeutic targets. It was therefore of interest to focus on central and peripheral biomarkers in Alzheimer's disease. Methods: A
APA, Harvard, Vancouver, ISO, and other styles
4

Ashford, J. Wesson, Frederick A. Schmitt, and Vinod Kumar. "Diagnosis of Alzheimer's Disease." Psychiatric Annals 26, no. 5 (May 1, 1996): 262–68. http://dx.doi.org/10.3928/0048-5713-19960501-06.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Reisberg, Barry, and Alistair Burns. "Diagnosis of Alzheimer's Disease." International Psychogeriatrics 9, S1 (December 1997): 5–7. http://dx.doi.org/10.1017/s1041610297004651.

Full text
Abstract:
This issue on the diagnosis of Alzheimer's disease (AD) is the product of a special meeting of the International Psychogeriatric Association with the cosponsorship of Alzheimer's Disease International, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association. The meeting was held in Geneva, Switzerland, from November 10 to 12, 1996. Participants included many of the leading experts on the various aspects of AD diagnosis as well as clinical experts, general experts in the field of AD, organizational representatives, and outstanding
APA, Harvard, Vancouver, ISO, and other styles
6

Lindley, R. I., and M. S. Dennis. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 47. http://dx.doi.org/10.1136/bmj.302.6767.47-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Manning, F. C. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 47–48. http://dx.doi.org/10.1136/bmj.302.6767.47-c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Byrne, E. J. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 48. http://dx.doi.org/10.1136/bmj.302.6767.48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tozer, R. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6767 (January 5, 1991): 48. http://dx.doi.org/10.1136/bmj.302.6767.48-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wald, N., C. Parkes, and A. D. Smith. "Diagnosis of Alzheimer's disease." BMJ 302, no. 6771 (February 2, 1991): 292. http://dx.doi.org/10.1136/bmj.302.6771.292-b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Alzheimer's disease – Diagnosis"

1

Wang, Xueli. "Organic molecules for diagnosis and therapy of Alzheimer's disease." HKBU Institutional Repository, 2020. https://repository.hkbu.edu.hk/etd_oa/883.

Full text
Abstract:
Alzheimer's disease has become one of the most common diseases jeopardizing the health of the human being. The main pathological feature of AD is the accumulation of Aβ in the brain to form senile plaques. Therefore, it is of great significance to develop new and efficient drugs targeting at amyloid-β for the detection, diagnosis and therapeutics for Alzheimer's disease. Xanthohumol (Xn) naturally presents in hops (Humulus lupulus L). Studies have shown that it has anti-lipoperoxidative, anti-inflammatory, anti-proliferative activities, antiangiogenic and antioxidant effects, which further ill
APA, Harvard, Vancouver, ISO, and other styles
2

Andreasen, Niels. "Search for reliable diagnostic markers for Alzheimer's disease /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4039-8/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Haigh, Anne-Marie Francoise. "The Alzheimer's Disease Life Events Study." Thesis, Oxford Brookes University, 2009. http://radar.brookes.ac.uk/radar/items/9c1acdb7-0df9-4046-ec50-810f9122e1d0/1.

Full text
Abstract:
The Alzheimer's Disease Life Events study examines whether there is a relationship between life events and Alzheimer's disease (AD). The ADLE study uses a mixed methods approach to answer the central research question:Are life events a risk factor for Alzheimer's disease? The central research question uses the following theory questions to examine:1. Is there a difference between the number of life events between patients and controls, using the Life Events and Difficulties Schedule (LEDS)(Brown and Harris, 1978) as a measurement tool?2. Is there a difference in the way (i.e. positive, neutral
APA, Harvard, Vancouver, ISO, and other styles
4

Bogdanovic, Nenad. "Alzheimer's disease : towards a multifaceted approach in neuropathological diagnosis /." Stockholm, 1998. http://diss.kib.ki.se/1998/91-628-2846-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sayeed, Abdul. "Positron emission tomography analysis of Alzheimer's disease." Thesis, University of Surrey, 2001. http://epubs.surrey.ac.uk/842834/.

Full text
Abstract:
Alzheimer's Disease (AD) is a major concern for the elderly population, currently affecting over 670,000 people in the UK. With the continual increase in the age of the population the problem is expected to rise. There is no known cure to the condition and a definite diagnosis cannot be made in life. Clinical diagnosis is considered to be approximately 80% - 90% accurate, sometimes taking up to a year to assess. Early detection could aid in the care and possible development of better treatments or even a cure. AD has been shown to alter the structure and global texture of the brain. Studies us
APA, Harvard, Vancouver, ISO, and other styles
6

Casson, Roland James. "Making sense of a diagnosis of Alzheimer's disease : partners' experiences." Thesis, University of Hertfordshire, 2004. http://hdl.handle.net/2299/14242.

Full text
Abstract:
Objectives This study aimed to explore the personal experiences and meanings that people develop in response to their partner being diagnosed with Alzheimer's disease, and how these inform the ways in which they cope with and manage their situation in the early stages. Method In-depth interviews were conducted with four women whose partners had received a diagnosis of early-stage Alzheimer's disease from specialist services within the past six months. Interpretative Phenomenological Analysis was used to identify themes running within their accounts. Results Three key themes emerged from the an
APA, Harvard, Vancouver, ISO, and other styles
7

Gonzalez, Murcia Josue David. "Diagnosis and the Role of Chemokine Receptors in Alzheimer's Disease." BYU ScholarsArchive, 2020. https://scholarsarchive.byu.edu/etd/8888.

Full text
Abstract:
Alzheimer’s disease (AD) is the most common neurodegenerative disorder and is the main cause of dementia in the elderly population. AD is pathologically characterized by the accumulation of amyloid plaques and neurofibrillary tangles that results in neurodegeneration and loss of memory function. However, diagnosis of AD and characterization of biological mechanisms that lead to pathology and modulate risk for disease has proven to be extremely difficult. Cerebrospinal fluid (CSF) contains critical biomarkers for AD such as levels of amyloid beta (Aβ) phosphorylated-tau (p-tau), total-tau (t-ta
APA, Harvard, Vancouver, ISO, and other styles
8

Fedotova, M. S. "Current issues in the diagnosis and treatment of Alzheimer's disease." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18901.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, André P. "Medicalizing intersubjectivity : diagnostic practices and the self in Alzheimer's disease." Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36792.

Full text
Abstract:
Alzheimer's disease (AD) is a condition marked by progressive intellectual decline and memory loss, which typically affects individuals over the age of 60. Its origins are unknown but genetic factors are suspected in some cases. There is limited information about the subjective experience of AD although it is often described as a calamity that inevitably destroys the self irrespective of its victims' social circumstances. This dissertation offers an alternative to this nihilistic portrayal that draws on a critical phenomenological framework. It explores the loss of self as an intersubjective p
APA, Harvard, Vancouver, ISO, and other styles
10

Kixmiller, Jeffrey S. "Subtyping patients with Senile Dementia of the Alzheimer type using cluster analysis." Virtual Press, 1992. http://liblink.bsu.edu/uhtbin/catkey/833474.

Full text
Abstract:
The purpose of this study was to determine if distinct subgroups of patients with Senile Dementia of the Alzheimer Type (SDAT) could be identified using seven scales of the Cognitive Behavior Rating Scale (CBRS). Ward's method of cluster analysis was used to group 104 patients with a probable diagnosis of SDAT into subtypes.The following three clusters were identified: (a) Moderately Impaired, (b) Severely Impaired, and (c) Emotionally Intact which displayed differences in symptom severity. Clusters could be partially defined by the amount of time they had been diagnosed with the disease. Diff
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Alzheimer's disease – Diagnosis"

1

Ronson, Charles E. Alzheimer's diagnosis. New York: Nova Science Publishers, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Boyd, Marisa R. Alzheimer's disease diagnosis and treatments. Hauppauge, N.Y: Nova Science, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Juergen, Bludau, ed. Alzheimer's disease. Santa Barbara, Calif: Greenwood, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Scinto, Leonard F. M., and Kirk R. Daffner. Early Diagnosis of Alzheimer's Disease. New Jersey: Humana Press, 2000. http://dx.doi.org/10.1385/1592590055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

1950-, Gauthier Serge, ed. Clinical diagnosis and management of Alzheimer's disease. 2nd ed. London: Martin Dunitz, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Khalid, Iqbal, and International Conference on Alzheimer's Disease and Related Disorders (5th : 1996 : Osaka, Japan), eds. Alzheimer's disease: Biology, diagnosis, and therapeutics. Chichester: Wiley, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Alistair, Burns, and Pettit William J, eds. Alzheimer's disease in primary care. London: Martin Dunitz, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Michaelides, Efstathios E. (Stathis). Alzheimer's disease: Methods and protocols. [Place of publication not identified]: Humana, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

E, Becker Robert, and Giacobini Ezio, eds. Alzheimer disease: Current research in early diagnosis. New York: Taylor & Francis, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Daniela, Galimberti, and Scarpani Elio, eds. Biomarkers for early diagnosis of Alzheimer's disease. New York: Nova Science, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Alzheimer's disease – Diagnosis"

1

Nagaraj, Siranjeevi, Madhu Ramesh, and Thimmaiah Govindaraju. "Chapter 14. Circulating Biomarkers for the Diagnosis of Alzheimer's Disease." In Alzheimer's Disease, 415–41. Cambridge: Royal Society of Chemistry, 2022. http://dx.doi.org/10.1039/9781839162732-00415.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rajkumar, Gomathi, Murugan Rajan, Mairim Russo Serafini, Narendra Narain, Adriano A. S. Araujo, Lucindo José Quintans Júnior, and Lijing Ke. "Inside Alzheimer's Disease Diagnosis." In Nanophytomedicine, 39–48. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003231745-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ramesh, Madhu, Sourav Samanta, and Thimmaiah Govindaraju. "Chapter 13. Molecular Probes for the Diagnosis of Alzheimer's Disease with Implications for Multiplexed and Multimodal Strategies." In Alzheimer's Disease, 377–414. Cambridge: Royal Society of Chemistry, 2022. http://dx.doi.org/10.1039/9781839162732-00377.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Menéndez González, Manuel. "Differential Diagnosis." In Atlas of Biomarkers for Alzheimer's Disease, 17–21. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07989-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Estrada, Lisbell D., and Claudio Soto. "Strategies for Alzheimer's Disease Diagnosis." In Current Hypotheses and Research Milestones in Alzheimer's Disease, 217–26. Boston, MA: Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-87995-6_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Richly, Pablo, Facundo Manes, and Julián Bustin. "Depression and Alzheimer's Disease." In Depression in Neurologic Disorders: Diagnosis and Management, 177–88. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781118348093.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gauthier, Serge. "Update on Alzheimer's Disease Diagnosis and Management." In The Care of the Older Person, 20–23. 5th ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003344476-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Menéndez González, Manuel. "Early Diagnosis and Risk of Conversion from Presymptomatic Stages." In Atlas of Biomarkers for Alzheimer's Disease, 1–15. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07989-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Arai, Tetsuaki. "Diagnostic Criteria for Alzheimer’s Disease." In Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias, 11–19. Tokyo: Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55133-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Matsuda, Hiroshi, and Etsuko Imabayashi. "Structural Neuroimaging in Alzheimer’s Disease." In Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias, 21–38. Tokyo: Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55133-1_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Alzheimer's disease – Diagnosis"

1

Senna, Priscylla de, Wyllians Borelli, Wagner Brum, Eduardo Zimmer, Márcia Chaves, Arthur Schuh, and Raphael Castilhos. "FUNCTIONAL COGNITIVE DISORDER AS THE MOST FREQUENT DIAGNOSIS IN PUBLIC MEMORY CLINIC." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda059.

Full text
Abstract:
Background: Functional cognitive disorder (FCD) has been described as a blind spot of dementia care. Objectives: Identify the frequency of FCD in a tertiary memory clinic (TMC). Methods: A retrospective analysis was conducted to identify new referrals from the primary care setting to a TMC from southern Brazil over 2014 to 2020. Diagnostic protocol included neurologic evaluation, cognitive screening, neuroimaging and laboratory testing. FCD was defined as cognitive complaints without objective cognitive decline, in the absence of evidence of neurodegenerative disease. Data is shown in mean (SD
APA, Harvard, Vancouver, ISO, and other styles
2

Jiao, Jianling, Timon C. Liu, Yan Li, and Songhao Liu. "Early neuroimaging diagnosis of Alzheimer's disease." In International Workshop on Photonics and Imaging in Biology and Medicine, edited by Qingming Luo, Britton Chance, and Valery V. Tuchin. SPIE, 2002. http://dx.doi.org/10.1117/12.462540.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Amira, Ben Rabeh, Benzarti Faouzi, Amiri Hamid, and Mouna Bouaziz. "Computer-assisted diagnosis of Alzheimer's disease." In 2014 First International Image Processing, Applications and Systems Conference (IPAS). IEEE, 2014. http://dx.doi.org/10.1109/ipas.2014.7043281.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Morgado, Pedro, Margarida Silveira, and Durval Campos Costa. "Texton-based diagnosis of Alzheimer's disease." In 2013 IEEE International Workshop on Machine Learning for Signal Processing (MLSP). IEEE, 2013. http://dx.doi.org/10.1109/mlsp.2013.6661913.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ramos, Júlia Xavier, Bruno Zacarias, Breno Barbosa, and Simone Brandão. "18-FDG PET ANALYSYS FOR DEMENTIA DIAGNOSIS- BASELINE RESULTS FROM A REFERENCE CENTER IN RECIFE, BRAZIL." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda061.

Full text
Abstract:
Background: Positrons emission tomography associated with computed tomography- PET/CT using the 18 F-fluorodeoxyglucose is a well-established exam for the medical evaluation of dementia, mainly helping in differential diagnosis to determine the specific type of dementia. Objectives: To describe the role of the PET/CT in the differential diagnosis of dementia in patients. Methods: a single-center, descriptive and records-based analysis of patients with Dementia evaluated in a clinic of Neurology at Recife and referred to PET/ CT due to diagnosis uncertainty, between 2020-2021. Results: 29 patie
APA, Harvard, Vancouver, ISO, and other styles
6

Santos, Roberto, and Rita Fernandes. "THE ACCURACY OF TRANSCRANIAL SONOGRAPHY ON ALZHEIMER’S DISEASE DIAGNOSIS." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda044.

Full text
Abstract:
Background: The diagnosis of Alzheimer’s disease (AD) is clinical, combining neurological examination, neuropsychological tests and neuroimaging. One of the anatomical features of AD is medial temporal lobe (MTL) atrophy graduated by magnetic resonance imaging (MRI) with accuracy to discriminate between healthy controls, mild neurocognitive disorder (MCI) or dementia, but it has its limitations. Transcranial sonography (TCS) demonstrated good accuracy to display changes in echogenicity or size of intracranial structures. Objective: The objective of this study is to evaluate TCS diagnostic accu
APA, Harvard, Vancouver, ISO, and other styles
7

Zawawi, Nour, Heba Gamal Saber, Mohamed Hashem, and Tarek F.Gharib. "Predicting Alzheimer's Disease Progression by Combining Multiple Measures." In 2nd International Conference on NLP Techniques and Applications (NLPTA 2021). Academy and Industry Research Collaboration Center (AIRCC), 2021. http://dx.doi.org/10.5121/csit.2021.111913.

Full text
Abstract:
Alzheimer's disease (AD) is a degenerative brain ailment that affects millions worldwide. It is the most common form of dementia. Patients with an early diagnosis of Alzheimer's disease have a strong chance of preventing additional brain damage by halting nerve cell death. At the same time, it begins to progress several years before any symptoms appear. The variety of data is the biggest problem encountered during diagnosis. Neurological examination, brain imaging, and often asked questions from his connected closed relatives are the three forms of data that a neurologist or geriatrics employs
APA, Harvard, Vancouver, ISO, and other styles
8

Sahumbaiev, Ivan, Anton Popov, Nataliia Ivanushkina, Javier Ramirez, and Juan Manuel Gorriz. "Florbetapir Image Analysis for Alzheimer's Disease Diagnosis." In 2018 IEEE 38th International Conference on Electronics and Nanotechnology (ELNANO). IEEE, 2018. http://dx.doi.org/10.1109/elnano.2018.8477516.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lodha, Priyanka, Ajay Talele, and Kishori Degaonkar. "Diagnosis of Alzheimer's Disease Using Machine Learning." In 2018 Fourth International Conference on Computing Communication Control and Automation (ICCUBEA). IEEE, 2018. http://dx.doi.org/10.1109/iccubea.2018.8697386.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vovk, Alla, Ameera Patel, and Dennis Chan. "Augmented Reality for Early Alzheimer's Disease Diagnosis." In CHI '19: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2019. http://dx.doi.org/10.1145/3290607.3313007.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Alzheimer's disease – Diagnosis"

1

Rostaminejad, Marzieh. Early Diagnosis of Alzheimer's disease using Electrochemical-based Nanobiosensors for miRNA Detection. Peeref, July 2022. http://dx.doi.org/10.54985/peeref.2207p6024343.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zuo, Lingyan, Fengting Zhu, Rui Wang, Hongyan Shuai, and Xin Yu. Music intervention affects the quality of life on Alzheimer’s disease: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2021. http://dx.doi.org/10.37766/inplasy2021.12.0055.

Full text
Abstract:
Review question / Objective: Inclusion criteria: population: 1) A randomized controlled study on the impact of music intervention on the QOL of patients with AD; 2) The participants in this study is patients with AD; 3) There is no significant difference among age, gender and education background in sorted groups before analysis which make these groups comparable; intervention: 1)Intervention Modality Music-based intervention; comparison: 1) All data were sorted into two groups: the music intervention group and the control group without any music intervention; outcome: 1) The indicators evalua
APA, Harvard, Vancouver, ISO, and other styles
3

Ma, Yunxing, Julia Brettschneider, and Joanna Collingwood. A systematic review and meta-analysis of cerebrospinal fluid amyloid and tau levels in patients progressing from Mild Cognitive Impairment to Alzheimer’s Disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0020.

Full text
Abstract:
Review question / Objective: Reported levels of amyloid-beta and tau in human cerebrospinal fluid (CSF) are evaluated to discover if these biochemical markers can predict the transition from Mild Cognitive Impairment (MCI) to Alzheimer’s disease (AD). A systematic review and quantitative meta-analyses are performed to test relationships between three potential biomarkers in CSF (Aβ(1-42), T-tau, and P-tau181) and the evolution of AD in longitudinal evaluations of levels relative to baseline, using prior-published experimental data. The primary focus of the analysis is on the period describing
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Alzheimer's disease – Diagnosis' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography